p16INK4a immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemia
Open Access
- 1 April 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (7) , 2620-2623
- https://doi.org/10.1182/blood.v99.7.2620
Abstract
We investigated the prognostic value of p16INK4aimmunocytochemistry (ICC) analysis in 126 cases of newly diagnosed childhood acute lymphoblastic leukemia (ALL). The incidence of negative p16INK4a ICC was 38.1% and was more frequent in T-lineage ALL. Overall survival (OS) and event-free survival (EFS) were significantly higher in patients with positive p16INK4a ICC than in patients with negative ICC (6 years OS, 90% versus 63%,P = .0014; 6 years EFS, 77.8% versus 55%,P = .0033). The p16INK4a ICC remained a significant prognostic factor within the subgroup of B-precursor ALL. Multivariate analysis showed that negative p16INK4a ICC was an independent prognostic factor for OS (relative risk [RR], 3.38;P = .02) and EFS (RR, 2.49; P = .018). Sequential study showed that p16INK4a expression remained stable during first relapse in most patients. These findings indicate that p16INK4a ICC is an independent factor of outcome in childhood ALL.Keywords
This publication has 14 references indexed in Scilit:
- Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotypeLeukemia, 2001
- Prognostic value of p16INK4a gene deletions in pediatric acute lymphoblastic leukemiaBlood, 2001
- INK4A/ARF deletions are acquired at relapse in childhood acute lymphoblastic leukaemia: a paired study on 25 patients using real-time polymerase chain reactionBritish Journal of Haematology, 2001
- The Cell Cycle Inhibitor p16INK4A Sensitizes Lymphoblastic Leukemia Cells to Apoptosis by Physiologic Glucocorticoid LevelsPublished by Elsevier ,2001
- Hemizygous p16INK4A deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapseBlood, 2001
- Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC reportLeukemia, 2000
- Homozygous Deletion of the p16/MTS1 Gene in Pediatric Acute Lymphoblastic Leukemia Is Associated With Unfavorable Clinical OutcomeBlood, 1997
- Acute leukemia in childrenCurrent Opinion in Hematology, 1996
- Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemiaBlood, 1995
- Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhoodBlood, 1995